Related Experiment Video
Updated: Aug 9, 2026

11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Correlation between cytometric features and mitotic frequency in human breast carcinoma
Cytometry
|January 1, 1981
Summary
The variance of nuclear area in breast cancer cells is the strongest predictor of tumor recurrence and mitotic rate. This single cytometric measure outperformed combined features in predicting tumor behavior.
Area of Science:
- Oncology
- Pathology
- Biomedical Engineering
Background:
- Accurate prediction of breast cancer recurrence is crucial for effective treatment planning.
- Cytometric analysis offers quantitative features for tumor characterization.
- Existing methods for predicting tumor behavior require further refinement.
Purpose of the Study:
- To evaluate the correlation between cytometric features and breast cancer aggressiveness.
- To identify key cytometric indicators of tumor mitotic frequency and recurrence.
- To develop and assess novel cytometric measures for improved prognostic accuracy.
Main Methods:
- Analysis of 22 cytometric features from 142 human breast cancer samples.
- Correlation of features with mitotic frequency, labeling index, and 3-year recurrence rates.
- Development of a composite cytometric measure using multiple regression analysis.
Main Results:
- Variance of nuclear area demonstrated the strongest correlation with mitotic frequency and recurrence rate.
- A novel composite measure combining four features did not surpass the predictive power of nuclear area variance.
- Multiple regression analysis confirmed the superior prognostic value of nuclear area variance.
Conclusions:
- Nuclear area variance is a highly significant cytometric predictor of breast cancer mitotic activity and recurrence.
- Simple, single-feature cytometric analysis can be more effective than complex composite measures.
- Cytometric feature analysis, particularly nuclear area variance, holds promise for improving breast cancer prognostication.

